Pharmacodynamics Flashcards

1
Q

What’s the difference between pharmacokinetics and pharmacodynamics?

A

Pharmacokinetics: Body’s effect on the drug: ADME = absorption, distribution, metabolism, excretion
PharmacoDynamics: Drug’s effect on the body: dose-response and drug-receptor relationships

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

__ is the cornerstone of pharmacology.

A

The receptor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

The __ is the drug whose interaction with the receptor __ a biological response.

A

agonist; stimulates

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Main effect

A

characteristic intended effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Side effect

A

unwanted or bothersome effect USUALLY RELATED to the main effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Toxic effect

A

harmful or adverse effect of the drug; generally NOT DIRECTLY RELATED to main effect
often related to excessively high drug concentrations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

“How quickly will the drug act?” is a question of … (pharmaco-dynamics or -kinetics)

A

Pharmacokinetics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are the the three general sites of drug action?

A

1) Intracellular
2) Extracellular
3) Cell surface

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Neutralization of excessive gastric acid by antacids is an example of which site of action?

A

Extracellular (also, heparin in preventing blood coagulation)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Hormone treatment is an example of which site of action?

A

Intracellular (also, cancer chemotherapy and infection tx)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Agonist

A

Drug that binds to receptor and stimulates a biological response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Antagonist

A

Drug that binds to a receptor without altering receptor function (doesn’t stimulate a response)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

EC(50)

A

The concentration of a drug at which the drug effect is either at 50% of its maximum or compared to another known drug with the same effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Law of mass action

A

[D] + [R] –> [DR] –> Effect

Words: Effect of a drug is directly proportional to the amount of drug-receptor complexes formed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Rate of association =

A

= k(1) [D][R]

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Rate of dissociation =

A

= k (-1) [DR]

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Equilibrium Dissociation Constant

A

rate of assoc. = rate of dissoc. at equilibrium; therefore, [D][R}/[DR] = K(D)

The lower the K(D) the higher the affinity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

How can you determine the number of occupied receptors from the drug concentration, max % of bound receptors (B) and K(D)?

A

C x B / C + K(D)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What are the three assumptions being made in the law of mass action?

A

1) binding is totally reversible
2) D and R only exist as free and bound
3) all receptor sites are considered to have equivalent affinity for D and to be independent (vs. cooperativity)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Potency

A

The dose of a drug required to produce a particular effect of given intensity (usually measured as ED50). A response measurement.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Affinity

A

The ability of the drug to interact with the receptor (measured as K(D)). Usually in vitro.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Efficacy

A

Biological response resulting from drug-receptor interaction. (Typically plotted along y-axis)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Maximal efficacy is often limited by ___.

24
Q

Partial agonist

A

Work by shifting equilibrium of a receptor to be stimulated more frequently but not as much so as the full agonist.

25
Look at the "example of concepts" slide to differentiate potency, efficacy, agonists, and partial agonists.
Just do it...
26
Log dose-response curve when adding competitive antagonist
Magnitude of shift to the right is proportional to the concentration of antagonist added; the shape and maximal response are not altered
27
Spare receptors
when a maximal response can be elicited by an agonist at a concentration that does not result in 100% occupancy of available receptors *Important in the action of irreversible antagonists*
28
What makes a competitive antagonist irreversible?
The covalent binding (usually to the same site as the agonist)
29
Noncompetitive antagonist
Different binding site; the antagonism cannot be completely reversed by increasing the concentration of agonist --> decrease Emax by occupying receptors ** Is reversible with drug withdrawal **
30
As dose of noncompetitive antagonist is increased the ___ is progressively decreased.
Maximal response
31
Functional (physiological) antagonism
two drugs influence the same physiological system but in opposite directions Exp. Ach decreased blood pressure, but can be offset by epinephrine
32
Chemical antagonism
Direct i/a of agonist and antagonist where they react and form an inactive product Exp. calcium-containing antacids and tetracycline antibiotics
33
Threshold of quantal log dose-response curves
The minimum effective dose of the drug which evokes an all-or-none response
34
How does one make a quantal dose-response curve?
Doses required to produce a specified (yes or no) effect are log-normally distributed. Responses are then summated for each given dose and the resulting cumulative frequency distribution constitutes the curve
35
ED(50)
= Median effective dose | = Dose required to produce the stated effect in 50% of the population
36
LD(50) or TD(50)
Dose required to produce death or a particular toxic effect in 50% of the population
37
Therapeutic Index
The relative safety of a drug expressed as the ratio of LD(50):ED(50) -Larger ratio--> greater relative safety
38
This type of drug produces its effects after a characteristic lag period (can not alter a pathologic state within minutes).
Intracellular/hormonal drugs *Effect can persist long after the agonist concentration is reduced to zero.*
39
What is an important structural characteristic of protein tyrosine kinases?
The span the lipid bilayer ONE time. --> Usually act as dimers. Exps. Insulin, EGF, and platelet derived growth factor receptors
40
How is protein tyrosine kinase activity turned off?
Receptor down regulation by stimulating endocytosis once the receptor is stimulated.
41
Ach, GABA, and many excitatory a.a. like glycine, aspartate, and glutamate are examples of _
Drugs that acts as ligands for gated ion channels
42
How does the lag of action in ligand-gated channels/drugs compare to intracellular drugs?
Time elapsed after ligand/agonist binding to cellular response is often milliseconds- much shorter than that of intracellular drugs that must induce genetic change to have an effect.
43
Adrenergic amines, serotonin, acetylcholine (for muscarinic effects) are examples of __.
Ligands for g-protein coupled receptors
44
Effector enzyme and target enzymes of cAMP
Effector enzyme- adenylyl cyclase | Stimulates cAMP-dependent protein kinases (also EPAC)
45
Effector enzyme and effects of phosphoinositides and diacylglycerol
Effector enzyme- phospholipase C (PLC)--> releases IP3 and DAG IP3-release of calcium DAG- can activate protein kinase C
46
Effector enzyme and effects of cGMP
Effector enzyme- guanyl cyclase Activates cGMP-dependent protein kinases *Much more specific than other messenger systems*
47
"Drug disposition tolerance"
a decrease in effective concentration of the agonist at the site of action--> decreased effect of drug Exp. Phenobarbital increases rate of biotransformation of a number of drugs which are metabolized by liver enzymes
48
"Cellular or pharmacologic tolerance"
a decrease in the normal reactivity of the receptors i.e. down regulation or change in receptor affinity Most often seen with CNS drugs (narcotics, depressants, stimulants)
49
Tachyphylaxis
ACUTE development of tolerance following rapid, repeated administration of a drug. Often happens when drugs have an indirect effect on target response. *Can NOT overcome this type of tolerance with increasing dose*
50
What is an example of a drug that causes tachyphylaxis?
Ephedrine
51
Idiosyncratic reaction
a genetically-determined abnormal reactivity to a drug ; often due to differences in drug metabolizing enzymes
52
Type I Hypersensitivity (briefly)
- Immediate hypersensitivity or anaphylaxis - IgE production - IgE becomes fixed to mast cells - Subsequent exposure causes drug to bind to IgE and histamine, PGs etc to be released
53
Type II Hypersensitivity (briefly)
- Antibody and complement mediated cytolytic reaction - Drug binds to cell surface --> makes cell look foreign - IgG and IgM activate classic complement system - Blood cells are primary target tissues * Subsides within months after removal of drug
54
Type III Hypersensitivity (briefly)
- Immune complexes - Drug reacts in the blood with soluble IgG - Immune complex is deposited in vascular endothelium - Cell mediated immune response--> local inflammation and complement activation - SERUM SICKNESS, hemolysis and allergic nephritis * Subsides 1-2 weeks after drug is removed
55
Type IV Hypersensitivity (EXTENDED VERSION)... jk (briefly)
- Delayed hypersensitivty (lymphocyte mediated) - Hours or days after exposure - Mediated by antigen contact with sensitized T cells and macrophages - Release of lymphokines/cytokines - Influx of neutrophils and macrophages - CONTACT DERMATITIS/TOPICAL DRUGS